期刊文献+

尿激酶型纤溶酶原激活物及其受体在膀胱移行细胞癌中表达的临床意义 被引量:3

Expression of urokinase type plasminogen activator and uPA receptor in transitional cell carcinoma of bladder
原文传递
导出
摘要 目的 探讨尿激酶型纤溶酶原激活物 (uPA)及其特异受体 (uPA R)与膀胱移行细胞癌生物学行为之间的关系。 方法 应用免疫组织化学方法检测 5 1例膀胱移行细胞癌组织中uPA及uPA R蛋白水平的表达。 结果 随膀胱移行细胞癌分级、分期的增高和转移的出现 ,uPA和uPA R表达明显增高 (P值分别 <0 0 1,0 0 5 ,0 0 1)。 结论 uPA及uPA R的阳性表达与膀胱移行细胞癌的浸润和转移能力增强有关 。 Objective To study the urokinase type plasminogen activator (uPA) and uPA receptor (uPA R) in transitional cell carcinoma of bladder. Methods Expressions of uPA and uPA R were stu died by means of immunocytochemistry in 51 cases of transitional cell carcinoma of bladder and in 10 normal bladder mucosa as controls. Results uPA and uPA R were both negative in normal bladder mucosa.Whereas,both the expressions were noted in the carcinoma tissues and their levels were intimately correlated to the grade,stage and metastasis of the tumor ( P <0.01,0.05,0.01 respectively). Conclusions Over expression of uPA and uPA R was significantly correlated to bladder cancer invasion and metastasis.
出处 《中华泌尿外科杂志》 CSCD 北大核心 2000年第8期465-466,共2页 Chinese Journal of Urology
关键词 膀胱肿瘤 膀胱移行细胞癌 UPA uPA-R Bladder neoplasms Carcinoma Urokinase-type
  • 相关文献

参考文献1

共引文献6

同被引文献12

  • 1Vassalli J D,Baccino D,Belin D. A cellular binding site for the Mr 55 000 from of the human plasminogen activator,Urokinase[J]. J Cell Biol,1985,100(1):86-92.
  • 2Foekens J A, Peters H A, Look M P,et al. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients[J]. Cancer Res, 2000, 60(3): 636-643.
  • 3Solomayer E F,Diel I J,Wallwiener D,et al. Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer[J]. Br J Cancer, 1997,76(6):812-818.
  • 4Hudson M A,McReynolds,L M. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines[J]. J Natl Cancer Inst,1997,89(10):709-717.
  • 5Arriagada R, Rulqvidt L E, Skoog, er al. Angnostic Factors and natural history in lymph node negative breast cancer paticnts. Breast Cancer Res Treat, 1992,21 : 101.
  • 6Kurebayashi JJ. Biologicl and Clinicl significancer of her2 overexpression in breast cancer. Breast Cancer,2001,8:45 -51.
  • 7Costa SD, Lange S, Klinga K, et al. Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer - results of the analysis of 670 pationts with 11 years of follow - up. European journal of cancer ( oxford, England : 1990) ,2002,38 ( 10 ) : 1329 - 34.
  • 8Andreasen PA, Kjoller L, Christensen L, et al. The urokinase - type plas- minogen activator system in cancer metastasis. Int J Cancer, 1997,72 ( 1 ) :1 -22.
  • 9Niu Y, Fu X, et al. Potential markers predicting distant metastasis in axillary node - negative breast carcinoma. International journal of cancer. Joumal international du. Cancer,2002,10,98 (5) :754 - 60.
  • 10Ariatidia Moustaksa, Sehiy Souchelnytakyi, Smad regulation in TCF - β Baignal tranaduction. Journal of Call Science 114,4359 - 4369 ( 2001 ).

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部